These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22889610)

  • 1. A-kinase anchoring proteins: molecular regulators of the cardiac stress response.
    Diviani D; Maric D; Pérez López I; Cavin S; Del Vescovo CD
    Biochim Biophys Acta; 2013 Apr; 1833(4):901-8. PubMed ID: 22889610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology.
    Diviani D; Reggi E; Arambasic M; Caso S; Maric D
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1926-36. PubMed ID: 26643253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of A-kinase anchoring proteins in cardiac oxidative stress.
    Diviani D; Osman H; Delaunay M; Kaiser S
    Biochem Soc Trans; 2019 Oct; 47(5):1341-1353. PubMed ID: 31671182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
    Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
    Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy.
    Rababa'h A; Singh S; Suryavanshi SV; Altarabsheh SE; Deo SV; McConnell BK
    Int J Mol Sci; 2014 Dec; 16(1):218-29. PubMed ID: 25547489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKAPs: the architectural underpinnings of local cAMP signaling.
    Kritzer MD; Li J; Dodge-Kafka K; Kapiloff MS
    J Mol Cell Cardiol; 2012 Feb; 52(2):351-8. PubMed ID: 21600214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mAKAP-a master scaffold for cardiac remodeling.
    Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins.
    Blant A; Czubryt MP
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1161-70. PubMed ID: 22856508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease.
    Mirtschink P; Krek W
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1822-8. PubMed ID: 26896647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local termination of 3'-5'-cyclic adenosine monophosphate signals: the role of A kinase anchoring protein-tethered phosphodiesterases.
    Stangherlin A; Zaccolo M
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):345-53. PubMed ID: 21654331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.
    Johnson KR; Nicodemus-Johnson J; Spindler MJ; Carnegie GK
    PLoS One; 2015; 10(7):e0132474. PubMed ID: 26192751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalized cyclic nucleotides have opposing effects on regulation of hypertrophic phospholipase Cε signaling in cardiac myocytes.
    Nash CA; Brown LM; Malik S; Cheng X; Smrcka AV
    J Mol Cell Cardiol; 2018 Aug; 121():51-59. PubMed ID: 29885334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
    Daskalopoulos EP; Dufeys C; Bertrand L; Beauloye C; Horman S
    J Mol Cell Cardiol; 2016 Feb; 91():188-200. PubMed ID: 26772531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
    Golatkar V; Bhatt LK
    Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast-mediated pathways in cardiac hypertrophy.
    Fujiu K; Nagai R
    J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anchoring proteins as regulators of signaling pathways.
    Perino A; Ghigo A; Scott JD; Hirsch E
    Circ Res; 2012 Aug; 111(4):482-92. PubMed ID: 22859670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-kinase anchoring protein targeting of protein kinase A in the heart.
    Ruehr ML; Russell MA; Bond M
    J Mol Cell Cardiol; 2004 Sep; 37(3):653-65. PubMed ID: 15350838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.